Constitutive and functionally relevant expression of JAM-C on platelets

Luise Erpenbeck; Simone Rubant; Katja Hardt; Sentot Santoso; Wolf-Henning Boehncke; Michael P. Schön; Ralf J. Ludwig

doi:10.1160/TH09-08-0572

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 103(04): 857-859
DOI: 10.1160/TH09-08-0572

Letters to the Editor

Schattauer GmbH

Constitutive and functionally relevant expression of JAM-C on platelets

Luise Erpenbeck

¹Department of Dermatology, Venereology and Allergology, Georg August University, Göttingen, Germany

²Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, Julius Maximilians University, Würzburg, Germany

,

Simone Rubant

³Department of Dermatology, Clinic of the Johann Wolfgang Goethe University, Frankfurt am Main, Germany

,

Katja Hardt

³Department of Dermatology, Clinic of the Johann Wolfgang Goethe University, Frankfurt am Main, Germany

,

Sentot Santoso

⁴Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Giessen, Germany

,

Wolf-Henning Boehncke

³Department of Dermatology, Clinic of the Johann Wolfgang Goethe University, Frankfurt am Main, Germany

,

Michael P. Schön^*

¹Department of Dermatology, Venereology and Allergology, Georg August University, Göttingen, Germany

²Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, Julius Maximilians University, Würzburg, Germany

,

Ralf J. Ludwig^*

¹Department of Dermatology, Venereology and Allergology, Georg August University, Göttingen, Germany

⁵Department of Dermatology, University of Lübeck, Lübeck, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Bazzoni G, Martinez-Estrada OM, Orsenigo F. et.al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 2000; 275: 20520-2056.
2 Ebnet K, Schulz CU, Meyer zu Brickwedde MK. et.al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 2000; 275: 27979-27988.
3 Kostrewa D, Brockhaus M, D’Arcy A. et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 2001; 20: 4391-4398.
4 Muller WA. Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation 2001; 08: 181-193.
5 Ody C, Jungblut-Ruault S, Cossali D. et al. Junctional adhesion molecule C (JAM-C) distinguishes CD27+ germinal center B lymphocytes from non-germinal center cells and constitutes a new diagnostic tool for B-cell malignancies. Leukemia 2007; 21: 1285-1293.
6 Immenschuh S, Naidu S, Chavakis T. et.al. Transcriptional induction of junctional adhesion molecule-C gene expression in activated T cells. J Leukoc Biol 2009; 85: 796-803.
7 Imhof BA, Zimmerli C, Gliki G. et al. Pulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-C-deficient mice. J Pathol 2007; 212: 198-208.
8 Palmer G, Busso N, Aurrand-Lions M. et al. Expression and function of junctional adhesion molecule-C in human and experimental arthritis. Arthritis Res Ther 2007; 09: R65.
9 Ludwig RJ, Zollner TM, Santoso S. et al. Junctional Adhesion Molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol 2005; 125: 969-976.
10 Lamagna C, Hodivala-Dilke KM, Imhof BA. et.al. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res 2005; 65: 5703-5710.
11 Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007; 07: 467-477.
12 Keiper T, Al-Fakhri N, Chavakis E. et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J 2005; 19: 2078-2080.
13 Shagdarsuren E, Djalali-Talab Y, Aurrand-Lions M. et al. Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief re-port. Arterioscler Thromb Vasc Biol 2009; 29: 1161-1163.
14 Kinashi T, Aker M, Sokolovsky-Eisenberg M. et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 2004; 103: 1033-1036.
15 Oostingh GJ, Ludwig RJ, Enders S. et al. Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions. J Invest Dermatol 2007; 127: 90-97.
16 Oostingh GJ, Pozgajova M, Ludwig RJ. et al. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica 2007; 92: 502-512.
17 Langer HF, Daub K, Braun G. et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 2007; 27: 1463-1470.
18 Ludwig RJ, Schön MP, Boehncke WH. P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets 2007; 11: 1103-1117.
19 Gelfand JM, Neimann AL, Shin DB. et.al. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006; 296: 1735-1741.
20 Ludwig RJ, Herzog C, Rostock A. et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-276.
21 Rubant SA, Ludwig RJ, Diehl S. et al. Dimethylfumarate Reduces Leukocyte Rolling in vivo through modulation of adhesion molecule expression. J Invest Dermatol 2007; 128: 326-331.